Andrew Brooks was a research professor at Rutgers University and CEO of Infinity Biologix, who developed the first FDA-approved rapid saliva test for COVID-19.Brooks joined the faculty at Rutgers in 2004, and in 2009, he began working at the university’s Cell and DNA Repository.
The company later went private, renamed Infinity Biologix, with Brooks at its helm. As the COVID-19 pandemic gripped the U.S.
in 2020, Brooks began leading the company’s effort to develop a saliva test. This test is able to produce faster results than a nasal or throat swab, without requiring a health worker to closely approach a potentially infected person to take a sample.
Read more on legacy.com
Get the latest stars news and celebrity rumours with exclusive stories, photos, videos and interviews.
Breaking up, scandals, engagements, divorces, gossip – all you need to know about the private lives of your favorite celebs.
Get to know the latest showbiz news along with exclusive interviews and even more. All this is waiting for you on the main page 24 hours a day, 7 days a week! Who, where, when, with whom, how, why and for what!? Stay tuned to know first!
Just follow us daily and we will provide you with the current news from the life of famous stars and celebrities.
Owner: SNOWLAND s.r.o.
Registration certificate 06691200
Address:
Snowland s.r.o.
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
Czech Republic
©2024. All rights reserved.